Organization name : Swiss Group for Clinical Cancer Research .
Organization study ID : SAKK 17/16 .
ClinicalTrials Identifier : NCT03213301 .
Updated : 2017_10_01 .
...
05 octubre 2017
Mesothelioma Malignant Pleural . Swiss Group for Clinical Cancer Research ha iniciado la Fase II con Zepsyre .
Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. A Multicenter, Single-arm Phase II Trial .
Organization name : Swiss Group for Clinical Cancer Research .
Organization study ID : SAKK 17/16 .
ClinicalTrials Identifier : NCT03213301 .
Updated : 2017_10_01 .
...
Organization name : Swiss Group for Clinical Cancer Research .
Organization study ID : SAKK 17/16 .
ClinicalTrials Identifier : NCT03213301 .
Updated : 2017_10_01 .
...